Issue: August 2016
August 01, 2016
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Trial Scorecard: CHANCE
Issue: August 2016
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Researchers conducted a subgroup analysis to determine if genetic variants played a role in clopidogrel effectiveness after minor stroke or transient ischemic attack.